Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Desplat

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 10, 2021
The widely used antihistamine mepyramine causes topical pain relief through direct blockade of nociceptor sodium channelsJizhe Hao, Lucie Brosse, Caroline Bonnet, et al.
Inflammation|December 6, 2024
TWEAK and TNFɑ Pro-inflammatory Soluble Cytokines and their Specific Autoantibodies Secretion in Multiple Sclerosis PatientsSylvie Carmona, Jehanne Aghzadi, Thierry Vincent, et al.
Journal of Clinical Gastroenterology|December 19, 2002
Autoimmune thrombotic thrombocytopenic purpura: a severe complication of inflammatory bowel diseaseNicolas Schleinitz, Valérie Faure, Emmanuelle Bernit, et al.
Journal of Neuroimmunology|November 26, 2002
TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severitySophie Desplat-Jégo, Simone Varriale, Rita Creidy, et al.
Journal of Translational Medicine|February 22, 2019
High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosisAdil Maarouf, Delphine Stephan, Marie-Pierre Ranjeva, et al.
Clinical Immunology (Orlando, Fla.)|July 20, 2005
Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitisSophie Desplat-Jégo, Rita Creidy, Simone Varriale, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Synthesis of new 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents by Suzuki-Miyaura cross-coupling reactionsJean Guillon, Isabelle Forfar, Vanessa Desplat, et al.
Glia|September 7, 2000
TWEAK stimulation of astrocytes and the proinflammatory consequencesP Saas, J Boucraut, P R Walker, et al.
International Journal of Molecular Sciences|July 25, 2019
Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?Solène Fernandez, Vanessa Desplat, Arnaud Villacreces, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 22, 2006
Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenesViviane Silva Pires, Francois Gaboriau, Jean Guillon, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 10, 2021
The widely used antihistamine mepyramine causes topical pain relief through direct blockade of nociceptor sodium channelsJizhe Hao, Lucie Brosse, Caroline Bonnet, et al.
Inflammation|December 6, 2024
TWEAK and TNFɑ Pro-inflammatory Soluble Cytokines and their Specific Autoantibodies Secretion in Multiple Sclerosis PatientsSylvie Carmona, Jehanne Aghzadi, Thierry Vincent, et al.
Journal of Clinical Gastroenterology|December 19, 2002
Autoimmune thrombotic thrombocytopenic purpura: a severe complication of inflammatory bowel diseaseNicolas Schleinitz, Valérie Faure, Emmanuelle Bernit, et al.
Journal of Neuroimmunology|November 26, 2002
TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severitySophie Desplat-Jégo, Simone Varriale, Rita Creidy, et al.
Journal of Translational Medicine|February 22, 2019
High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosisAdil Maarouf, Delphine Stephan, Marie-Pierre Ranjeva, et al.
Clinical Immunology (Orlando, Fla.)|July 20, 2005
Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitisSophie Desplat-Jégo, Rita Creidy, Simone Varriale, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Synthesis of new 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents by Suzuki-Miyaura cross-coupling reactionsJean Guillon, Isabelle Forfar, Vanessa Desplat, et al.
Glia|September 7, 2000
TWEAK stimulation of astrocytes and the proinflammatory consequencesP Saas, J Boucraut, P R Walker, et al.
International Journal of Molecular Sciences|July 25, 2019
Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?Solène Fernandez, Vanessa Desplat, Arnaud Villacreces, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 22, 2006
Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenesViviane Silva Pires, Francois Gaboriau, Jean Guillon, et al.
Pageof 14